70/100B101.820
USD
-3.03
(-2.89%)
Pre Open
Last updated: · Delayed 15 min
Fair value103.28Plus-1%77Price 101.82180
Q2 FY2027 · Earnings report
EPS estimate 1.33Revenue estimate 9.48B
Q2 FY2027 · Earnings report
EPS estimate 1.33Revenue estimate 9.48B
Medtronic price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Medtronic's P/S ratio is 3.47: its market cap of 130.25B USD over revenue of 37.54B USD in the last twelve months.
- Today
- 3.47
- Average, 5 years
- 3.56
- Low, 5 years
- 2.66
- High, 5 years
- 5.21
P/S ratio = market cap ÷ revenue (last 12 months) = 130.25B ÷ 37.54B = 3.47
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 3.47 | 130.25B | 37.54B | |
| FY2026 | 24 Apr 2026 | 2.94 | 106.80B | 36.36B |
| FY2025 | 25 Apr 2025 | 3.23 | 108.20B | 33.54B |
| FY2024 | 26 Apr 2024 | 3.27 | 105.87B | 32.36B |
| FY2023 | 28 Apr 2023 | 3.87 | 120.95B | 31.23B |
| FY2022 | 29 Apr 2022 | 4.42 | 140.09B | 31.69B |
| FY2021 | 30 Apr 2021 | 5.85 | 176.07B | 30.12B |
| FY2020 | 30 Apr 2020 | 4.53 | 130.89B | 28.91B |
| FY2019 | 26 Apr 2019 | 3.85 | 117.61B | 30.56B |
| FY2018 | 27 Apr 2018 | 3.68 | 110.29B | 29.95B |
| FY2017 | 28 Apr 2017 | 3.86 | 114.57B | 29.71B |
| FY2016 | 29 Apr 2016 | 3.87 | 111.57B | 28.83B |
| FY2015 | 30 Apr 2015 | 4.03 | 81.56B | 20.26B |
| FY2014 | 25 Apr 2014 | 3.43 | 58.33B | 17.01B |
| FY2013 | 30 Apr 2013 | 2.87 | 47.58B | 16.59B |
| FY2012 | 30 Apr 2012 | 2.49 | 40.26B | 16.18B |
| FY2011 | 30 Apr 2011 | 2.82 | 44.98B | 15.93B |
| FY2010 | 30 Apr 2010 | 3.06 | 48.33B | 15.82B |
| FY2009 | 30 Apr 2009 | 2.46 | 35.90B | 14.60B |
| FY2008 | 30 Apr 2008 | 4.07 | 55.04B | 13.52B |
| FY2007 | 30 Apr 2007 | 4.95 | 60.85B | 12.30B |
| FY2006 | 30 Apr 2006 | 5.33 | 60.16B | 11.29B |
| FY2005 | 30 Apr 2005 | 6.35 | 63.81B | 10.05B |
| FY2004 | 30 Apr 2004 | 6.74 | 61.24B | 9.09B |
| FY2003 | 30 Apr 2003 | 7.58 | 58.12B | 7.67B |
| FY2002 | 30 Apr 2002 | 8.45 | 54.15B | 6.41B |
| FY2001 | 30 Apr 2001 | 9.66 | 53.65B | 5.55B |
| FY2000 | 30 Apr 2000 | 12.45 | 62.42B | 5.01B |
| FY1999 | 30 Apr 1999 | 10.24 | 42.34B | 4.13B |
| FY1998 | 30 Apr 1998 | 11.70 | 30.48B | 2.60B |
| FY1997 | 30 Apr 1997 | 8.12 | 19.79B | 2.44B |
| FY1996 | 30 Apr 1996 | 5.83 | 12.64B | 2.17B |
| FY1995 | 30 Apr 1995 | 4.85 | 8.45B | 1.74B |
| FY1994 | 30 Apr 1994 | 3.10 | 4.32B | 1.39B |
| FY1993 | 30 Apr 1993 | 2.89 | 3.84B | 1.33B |
| FY1992 | 30 Apr 1992 | 3.30 | 3.89B | 1.18B |
| FY1991 | 30 Apr 1991 | 3.25 | 3.32B | 1.02B |
| FY1990 | 30 Apr 1990 | 2.15 | 1.80B | 836.60M |
| FY1989 | 30 Apr 1989 | 1.75 | 1.30B | 741.70M |
| FY1988 | 30 Apr 1988 | 1.58 | 1.03B | 653.30M |
| FY1987 | 30 Apr 1987 | 2.27 | 1.14B | 502.00M |
| FY1986 | 30 Apr 1986 | 2.23 | 898.90M | 402.80M |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q1 FY2027 | 31 Jul 2026 | 2.91 | 109.28B | 37.54B |
| Q4 FY2026 | 30 Apr 2026 | 2.85 | 103.79B | 36.36B |
| Q3 FY2026 | 31 Jan 2026 | 3.72 | 132.01B | 35.48B |
| Q2 FY2026 | 31 Oct 2025 | 3.34 | 116.26B | 34.76B |
| Q1 FY2026 | 31 Jul 2025 | 3.38 | 115.65B | 34.20B |
| Q4 FY2025 | 25 Apr 2025 | 3.22 | 107.92B | 33.54B |
| Q3 FY2025 | 31 Jan 2025 | 3.51 | 116.47B | 33.20B |
| Q2 FY2025 | 31 Oct 2024 | 3.47 | 114.45B | 33.00B |
| Q1 FY2025 | 26 Jul 2024 | 3.12 | 101.78B | 32.58B |
| Q4 FY2024 | 26 Apr 2024 | 3.26 | 105.44B | 32.36B |
| Q3 FY2024 | 26 Jan 2024 | 3.56 | 115.07B | 32.32B |
| Q2 FY2024 | 27 Oct 2023 | 2.89 | 92.36B | 31.96B |
| Q1 FY2024 | 28 Jul 2023 | 3.72 | 117.42B | 31.56B |
| Q4 FY2023 | 28 Apr 2023 | 3.87 | 121.00B | 31.23B |
| Q3 FY2023 | 27 Jan 2023 | 3.57 | 109.85B | 30.77B |
| Q2 FY2023 | 28 Oct 2022 | 3.75 | 115.42B | 30.81B |
| Q1 FY2023 | 29 Jul 2022 | 3.96 | 123.00B | 31.07B |
| Q4 FY2022 | 29 Apr 2022 | 4.41 | 139.59B | 31.69B |
| Q3 FY2022 | 28 Jan 2022 | 4.36 | 138.58B | 31.79B |
| Q2 FY2022 | 29 Oct 2021 | 5.07 | 161.22B | 31.80B |
| Q1 FY2022 | 30 Jul 2021 | 5.59 | 176.55B | 31.60B |
| Q4 FY2021 | 30 Apr 2021 | 5.86 | 176.39B | 30.12B |
| Q3 FY2021 | 29 Jan 2021 | 5.37 | 149.89B | 27.93B |
| Q2 FY2021 | 30 Oct 2020 | 4.85 | 135.21B | 27.87B |
| Q1 FY2021 | 31 Jul 2020 | 4.64 | 129.47B | 27.93B |
| Q4 FY2020 | 30 Apr 2020 | 4.53 | 130.88B | 28.91B |
| Q3 FY2020 | 31 Jan 2020 | 4.98 | 154.75B | 31.06B |
| Q2 FY2020 | 31 Oct 2019 | 4.73 | 146.01B | 30.89B |
| Q1 FY2020 | 26 Jul 2019 | 4.48 | 137.50B | 30.67B |
| Q4 FY2019 | 26 Apr 2019 | 3.83 | 117.10B | 30.56B |
| Q3 FY2019 | 31 Jan 2019 | 3.88 | 118.69B | 30.56B |
| Q2 FY2019 | 26 Oct 2018 | 3.99 | 121.09B | 30.38B |
| Q1 FY2019 | 27 Jul 2018 | 4.00 | 119.93B | 29.95B |
| Q4 FY2018 | 27 Apr 2018 | 3.68 | 110.14B | 29.95B |
| Q3 FY2018 | 26 Jan 2018 | 3.95 | 117.49B | 29.73B |
| Q2 FY2018 | 27 Oct 2017 | 3.72 | 110.17B | 29.64B |
| Q1 FY2018 | 28 Jul 2017 | 3.83 | 114.79B | 29.93B |
| Q4 FY2017 | 28 Apr 2017 | 3.83 | 113.75B | 29.71B |
| Q3 FY2017 | 27 Jan 2017 | 3.50 | 102.85B | 29.36B |
| Q2 FY2017 | 28 Oct 2016 | 3.90 | 113.06B | 29.01B |
| Q1 FY2017 | 29 Jul 2016 | 4.25 | 122.00B | 28.73B |
| Q4 FY2016 | 29 Apr 2016 | 3.85 | 110.87B | 28.83B |
| Q3 FY2016 | 29 Jan 2016 | 3.74 | 106.79B | 28.57B |
| Q2 FY2016 | 30 Oct 2015 | 4.02 | 104.44B | 25.95B |
| Q1 FY2016 | 31 Jul 2015 | 4.78 | 111.16B | 23.26B |
| Q4 FY2015 | 30 Apr 2015 | 5.23 | 105.89B | 20.26B |
| Q3 FY2015 | 31 Jan 2015 | 4.01 | 70.24B | 17.52B |
| Q2 FY2015 | 31 Oct 2014 | 3.85 | 66.93B | 17.37B |
| Q1 FY2015 | 31 Jul 2014 | 3.56 | 61.28B | 17.20B |
| Q4 FY2014 | 30 Apr 2014 | 3.46 | 58.82B | 17.01B |
| Q3 FY2014 | 31 Jan 2014 | 3.34 | 56.46B | 16.90B |
| Q2 FY2014 | 31 Oct 2013 | 3.42 | 57.34B | 16.76B |
| Q1 FY2014 | 31 Jul 2013 | 3.35 | 55.78B | 16.66B |
| Q4 FY2013 | 30 Apr 2013 | 2.85 | 47.34B | 16.59B |
| Q3 FY2013 | 31 Jan 2013 | 2.87 | 47.18B | 16.43B |
| Q2 FY2013 | 31 Oct 2012 | 2.60 | 42.39B | 16.32B |
| Q1 FY2013 | 31 Jul 2012 | 2.48 | 40.59B | 16.36B |
| Q4 FY2012 | 30 Apr 2012 | 2.42 | 39.73B | 16.40B |
| Q3 FY2012 | 31 Jan 2012 | 2.48 | 40.67B | 16.39B |
| Q2 FY2012 | 31 Oct 2011 | 2.24 | 36.76B | 16.44B |
| Q1 FY2012 | 31 Jul 2011 | 2.29 | 37.09B | 16.21B |
| Q4 FY2011 | 30 Apr 2011 | 2.80 | 44.68B | 15.93B |
| Q3 FY2011 | 31 Jan 2011 | 2.60 | 41.15B | 15.83B |
| Q2 FY2011 | 31 Oct 2010 | 2.42 | 37.98B | 15.72B |
| Q1 FY2011 | 31 Jul 2010 | 2.56 | 40.15B | 15.66B |
| Q4 FY2010 | 30 Apr 2010 | 3.04 | 48.07B | 15.82B |
| Q3 FY2010 | 31 Jan 2010 | 3.09 | 47.68B | 15.45B |
| Q2 FY2010 | 31 Oct 2009 | 2.62 | 39.51B | 15.09B |
| Q1 FY2010 | 31 Jul 2009 | 2.66 | 39.41B | 14.83B |
| Q4 FY2009 | 30 Apr 2009 | 2.44 | 35.68B | 14.60B |
| Q3 FY2009 | 31 Jan 2009 | 2.56 | 37.48B | 14.63B |
| Q2 FY2009 | 31 Oct 2008 | 3.12 | 45.35B | 14.54B |
| Q1 FY2009 | 31 Jul 2008 | 4.22 | 59.44B | 14.10B |
| Q4 FY2008 | 30 Apr 2008 | 4.05 | 54.72B | 13.52B |
| Q3 FY2008 | 31 Jan 2008 | 4.05 | 52.40B | 12.94B |
| Q2 FY2008 | 31 Oct 2007 | 4.27 | 53.75B | 12.58B |
| Q1 FY2008 | 31 Jul 2007 | 4.60 | 57.70B | 12.53B |
| Q4 FY2007 | 30 Apr 2007 | 4.93 | 60.68B | 12.30B |
| Q3 FY2007 | 31 Jan 2007 | 5.08 | 61.41B | 12.09B |
| Q2 FY2007 | 31 Oct 2006 | 4.74 | 55.95B | 11.81B |
| Q1 FY2007 | 31 Jul 2006 | 5.07 | 58.29B | 11.50B |
| Q4 FY2006 | 30 Apr 2006 | 5.26 | 59.43B | 11.29B |
| Q3 FY2006 | 31 Jan 2006 | 6.20 | 68.24B | 11.00B |
| Q2 FY2006 | 31 Oct 2005 | 6.36 | 68.48B | 10.76B |
| Q1 FY2006 | 31 Jul 2005 | 6.29 | 65.40B | 10.40B |
| Q4 FY2005 | 30 Apr 2005 | 6.33 | 63.67B | 10.05B |
| Q3 FY2005 | 31 Jan 2005 | 6.38 | 63.42B | 9.94B |
| Q2 FY2005 | 31 Oct 2004 | 6.38 | 61.31B | 9.61B |
| Q1 FY2005 | 31 Jul 2004 | 6.41 | 60.05B | 9.37B |
| Q4 FY2004 | 30 Apr 2004 | 6.72 | 61.08B | 9.09B |
| Q3 FY2004 | 31 Jan 2004 | 6.96 | 59.64B | 8.57B |
| Q2 FY2004 | 31 Oct 2003 | 6.68 | 55.34B | 8.29B |
| Q1 FY2004 | 31 Jul 2003 | 7.82 | 62.71B | 8.02B |
| Q4 FY2003 | 30 Apr 2003 | 7.59 | 58.17B | 7.67B |
| Q3 FY2003 | 31 Jan 2003 | 7.50 | 54.82B | 7.31B |
| Q2 FY2003 | 31 Oct 2002 | 7.79 | 54.46B | 6.99B |
| Q1 FY2003 | 31 Jul 2002 | 7.36 | 49.09B | 6.67B |
| Q4 FY2002 | 30 Apr 2002 | 8.45 | 54.18B | 6.41B |
| Q3 FY2002 | 31 Jan 2002 | 9.73 | 59.73B | 6.14B |
| Q2 FY2002 | 31 Oct 2001 | 8.26 | 48.77B | 5.91B |
| Q1 FY2002 | 31 Jul 2001 | 10.20 | 58.11B | 5.70B |
| Q4 FY2001 | 30 Apr 2001 | 9.70 | 53.84B | 5.55B |
| Q3 FY2001 | 31 Jan 2001 | 11.93 | 65.19B | 5.47B |
| Q2 FY2001 | 31 Oct 2000 | 12.15 | 65.16B | 5.36B |
| Q1 FY2001 | 31 Jul 2000 | 11.86 | 61.22B | 5.16B |
| Q4 FY2000 | 30 Apr 2000 | 12.60 | 62.47B | 4.96B |
| Q3 FY2000 | 31 Jan 2000 | 11.77 | 54.64B | 4.64B |
| Q2 FY2000 | 31 Oct 1999 | 9.62 | 42.55B | 4.42B |
| Q1 FY2000 | 31 Jul 1999 | 10.70 | 42.70B | 3.99B |
| Q4 FY1999 | 30 Apr 1999 | 11.89 | 42.08B | 3.54B |
| Q3 FY1999 | 31 Jan 1999 | 14.82 | 46.04B | 3.11B |
| Q2 FY1999 | 31 Oct 1998 | 14.09 | 38.03B | 2.70B |
| Q1 FY1999 | 31 Jul 1998 | 13.55 | 35.38B | 2.61B |
| Q4 FY1998 | 30 Apr 1998 | 11.66 | 30.38B | 2.60B |
| Q3 FY1998 | 31 Jan 1998 | 11.07 | 28.34B | 2.56B |
| Q2 FY1998 | 31 Oct 1997 | 7.79 | 19.70B | 2.53B |
| Q1 FY1998 | 31 Jul 1997 | 8.04 | 19.97B | 2.48B |
| Q4 FY1997 | 30 Apr 1997 | 6.53 | 15.91B | 2.44B |
| Q3 FY1997 | 31 Jan 1997 | 6.58 | 15.75B | 2.39B |
| Q2 FY1997 | 31 Oct 1996 | 6.34 | 14.75B | 2.32B |
| Q1 FY1997 | 31 Jul 1996 | 4.80 | 10.77B | 2.24B |
| Q4 FY1996 | 30 Apr 1996 | 5.56 | 12.06B | 2.17B |
| Q3 FY1996 | 31 Jan 1996 | 6.21 | 12.97B | 2.09B |
| Q2 FY1996 | 31 Oct 1995 | 6.38 | 12.59B | 1.97B |
| Q1 FY1996 | 31 Jul 1995 | 4.99 | 9.29B | 1.86B |
| Q4 FY1995 | 30 Apr 1995 | 4.70 | 8.18B | 1.74B |
| Q3 FY1995 | 31 Jan 1995 | 4.09 | 6.62B | 1.62B |
| Q2 FY1995 | 31 Oct 1994 | 3.70 | 5.69B | 1.54B |
| Q1 FY1995 | 31 Jul 1994 | 3.03 | 4.43B | 1.46B |
| Q4 FY1994 | 30 Apr 1994 | 2.75 | 3.82B | 1.39B |
| Q3 FY1994 | 31 Jan 1994 | 3.15 | 4.27B | 1.36B |
| Q2 FY1994 | 31 Oct 1993 | 2.81 | 3.74B | 1.33B |
| Q1 FY1994 | 31 Jul 1993 | 2.50 | 3.33B | 1.33B |
| Q4 FY1993 | 30 Apr 1993 | 2.94 | 3.91B | 1.33B |
| Q3 FY1993 | 31 Jan 1993 | 4.09 | 5.33B | 1.30B |
| Q2 FY1993 | 31 Oct 1992 | 4.02 | 5.20B | 1.29B |
| Q1 FY1993 | 31 Jul 1992 | 3.61 | 4.49B | 1.24B |
| Q4 FY1992 | 30 Apr 1992 | 2.74 | 3.22B | 1.18B |
| Q3 FY1992 | 31 Jan 1992 | 3.79 | 4.26B | 1.12B |
| Q2 FY1992 | 31 Oct 1991 | 3.52 | 3.79B | 1.08B |
| Q1 FY1992 | 31 Jul 1991 | 3.41 | 3.59B | 1.05B |
| Q4 FY1991 | 30 Apr 1991 | 2.94 | 2.98B | 1.01B |
| Q3 FY1991 | 31 Jan 1991 | 2.54 | 2.46B | 968.60M |
| Q2 FY1991 | 31 Oct 1990 | 2.04 | 1.89B | 923.80M |
| Q1 FY1991 | 31 Jul 1990 | 2.09 | 1.81B | 869.80M |
| Q4 FY1990 | 30 Apr 1990 | 1.61 | 1.35B | 836.60M |
| Q3 FY1990 | 31 Jan 1990 | 1.69 | 1.35B | 797.80M |
| Q2 FY1990 | 31 Oct 1989 | 2.07 | 1.61B | 777.20M |
| Q1 FY1990 | 31 Jul 1989 | 1.95 | 1.48B | 757.80M |
| Q4 FY1989 | 30 Apr 1989 | 1.69 | 1.26B | 741.70M |
| Q3 FY1989 | 31 Jan 1989 | 1.49 | 1.09B | 733.00M |
| Q2 FY1989 | 31 Oct 1988 | 1.55 | 1.11B | 713.50M |
| Q1 FY1989 | 31 Jul 1988 | 1.54 | 1.06B | 684.50M |
| Q4 FY1988 | 30 Apr 1988 | 1.55 | 1.01B | 653.30M |
| Q3 FY1988 | 31 Jan 1988 | 1.99 | 1.21B | 608.00M |
| Q2 FY1988 | 31 Oct 1987 | 1.91 | 1.07B | 562.50M |
| Q1 FY1988 | 31 Jul 1987 | 2.66 | 1.41B | 530.40M |
| Q4 FY1987 | 30 Apr 1987 | 2.48 | 1.25B | 502.00M |
| Q3 FY1987 | 31 Jan 1987 | 2.35 | 1.10B | 469.20M |
| Q2 FY1987 | 31 Oct 1986 | 2.78 | 1.24B | 447.50M |
| Q1 FY1987 | 31 Jul 1986 | 2.65 | 1.13B | 428.10M |
| Q4 FY1986 | 30 Apr 1986 | — | 928.68M | — |
| Q3 FY1986 | 31 Jan 1986 | — | 671.08M | — |
| Q2 FY1986 | 31 Oct 1985 | — | 585.13M | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Medtronic's P/S ratio
Source: Financial Modeling Prep